Sebastien Bauquier

Dr. Sebastien Bauquier

Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Werribee, VIC 3030, Australia
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2016 in Nature Biotechnology
Verified
Journal Article
Closed access
TOThomas J Oxley
Thomas J Oxley
NONicholas L Opie
Nicholas L Opie
SJSam John
Sam John
GRGil S Rind
Gil S Rind
SRStephen M Ronayne
Stephen M Ronayne
TOTerence J O'BRien
Terence J O'BRien

17 May 2017 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
CBClaudia Di Bella
Claudia Di Bella
SDSerena Duchi
Serena Duchi
COCathal D. O'Connell
Cathal D. O'Connell
RBRomane Blanchard
Romane Blanchard
CACheryl Augustine
Cheryl Augustine
Peter ChoongPeter Choong
Peter Choong

1 February 2015 in The Veterinary Journal
Verified
Journal Article
Open access
LWLeon Norris Warne
Leon Norris Warne
TBThierry Beths
Thierry Beths
TWTed Whittem
Ted Whittem
JCJennifer E. Carter
Jennifer E. Carter
SBSebastien Bauquier
Sebastien Bauquier
Alfaxalone-2-hydroxpropyl-β-cyclodextrin (alfaxalone-HPCD) was first marketed for veterinary use in Australia in 2001 and has since progressively became available throughout the world, including the USA, where in 2012 Food and Drug Administration (FDA) registration was granted. Despite the growing body of published works and increasing global availability of alfaxalone-HPCD, the accumulating evidence for its use in cats has not been thoroughly reviewed. The purpose of this review is: (1) to detail the pharmacokinetic properties of alfaxalone-HPCD in cats; (2) to assess the pharmacodynamic properties of alfaxalone-HPCD, including its cardiovascular, respiratory, central nervous system, neuromuscular, hepatic, renal, haematological, blood-biochemical, analgesic and endocrine effects; and (3) to consider the clinical application of alfaxalone-HPCD for sedation, induction and maintenance of anaesthesia in cats. Based on the published literature, alfaxalone-HPCD provides a good alternative to the existing intravenous anaesthetic options for healthy cats.

30 May 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SJSam John
Sam John
NONicholas L. Opie
Nicholas L. Opie
YWYan T. Wong
Yan T. Wong
GRGil S. Rind
Gil S. Rind
SRStephen M. Ronayne
Stephen M. Ronayne
TOThomas J. Oxley
Thomas J. Oxley
Recent work has demonstrated the feasibility of minimally-invasive implantation of electrodes into a cortical blood vessel. However, the effect of the dura and blood vessel on recording signal quality is not understood and may be a critical factor impacting implementation of a closed-loop endovascular neuromodulation system. The present work compares the performance and recording signal quality of a minimally-invasive endovascular neural interface with conventional subdural and epidural interfaces. We compared bandwidth, signal-to-noise ratio, and spatial resolution of recorded cortical signals using subdural, epidural and endovascular arrays four weeks after implantation in sheep. We show that the quality of the signals (bandwidth and signal-to-noise ratio) of the endovascular neural interface is not significantly different from conventional neural sensors. However, the spatial resolution depends on the array location and the frequency of recording. We also show that there is a direct correlation between the signal-noise-ratio and classification accuracy, and that decoding accuracy is comparable between electrode arrays. These results support the consideration for use of an endovascular neural interface in a clinical trial of a novel closed-loop neuromodulation technology.

1 April 2018 in Journal of Neurosurgery
Verified
Journal Article
Closed access
TOThomas James Oxley
Thomas James Oxley
NONicholas Lachlan Opie
Nicholas Lachlan Opie
GRGil Simon Rind
Gil Simon Rind
KLKishan Liyanage
Kishan Liyanage
SJSam Emmanuel John
Sam Emmanuel John
CMClive N. May
Clive N. May
OBJECTIVE: Neural interface technology may enable the development of novel therapies to treat neurological conditions, including motor prostheses for spinal cord injury. Intracranial neural interfaces currently require a craniotomy to achieve implantation and may result in chronic tissue inflammation. Novel approaches are required that achieve less invasive implantation methods while maintaining high spatial resolution. An endovascular stent electrode array avoids direct brain trauma and is able to record electrocorticography in local cortical tissue from within the venous vasculature. The motor area in sheep runs in a parasagittal plane immediately adjacent to the superior sagittal sinus (SSS). The authors aimed to develop a sheep model of cerebral venography that would enable validation of an endovascular neural interface.METHODS: Cerebral catheter venography was performed in 39 consecutive sheep. Contrast-enhanced MRI of the brain was performed on 13 animals. Multiple telescoping coaxial catheter systems were assessed to determine the largest wide-bore delivery catheter that could be delivered into the anterior SSS. Measurements of SSS diameter and distance from the motor area were taken. The location of the motor area was determined in relation to lateral and superior projections of digital subtraction venography images and confirmed on MRI.RESULTS: The venous pathway from the common jugular vein (7.4 mm) to the anterior SSS (1.2 mm) was technically challenging to selectively catheterize. The SSS coursed immediately adjacent to the motor cortex (< 1 mm) for a length of 40 mm, or the anterior half of the SSS. Attempted access with 5-Fr and 6-Fr delivery catheters was associated with longer procedure times and higher complication rates. A 4-Fr catheter (internal lumen diameter 1.1 mm) was successful in accessing the SSS in 100% of cases with no associated complications. Complications included procedure-related venous dissection in two major areas: the torcular herophili, and the anterior formation of the SSS. The bifurcation of the cruciate sulcal veins with the SSS was a reliable predictor of the commencement of the motor area.CONCLUSIONS: The ovine model for cerebral catheter venography has generalizability to the human cerebral venous system in relation to motor cortex location. This novel model may facilitate the development of the novel field of endovascular neural interfaces that may include preclinical investigations for cortical recording applications such as paralysis and epilepsy, as well as other potential applications in neuromodulation.

15 September 2013 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Closed access
LWLeon Norris Warne
Leon Norris Warne
TBThierry Beths
Thierry Beths
MHMerete Holm
Merete Holm
SBSebastien Bauquier
Sebastien Bauquier
Objective—To compare the perioperative analgesic effect between methadone and butorphanol in cats. Design—Randomized controlled clinical trial. Animals—22 healthy female domestic cats. Procedures—Cats admitted for ovariohysterectomy were allocated to a butorphanol group (n = 10) or methadone group (12) and premedicated with butorphanol (0.4 mg/kg [0.18 mg/lb], SC) or methadone (0.6 mg/kg [0.27 mg/lb], SC), respectively, in combination with acepromazine (0.02 mg/kg [0.01 mg/lb], SC). Anesthesia was induced with propofol (IV) and maintained with isoflurane in oxygen. A multidimensional composite scale was used to conduct pain assessments prior to premedication and 5, 20, 60, 120, 180, 240, 300, and 360 minutes after extubation or until rescue analgesia was given. Groups were compared to evaluate isoflurane requirement, propofol requirement, pain scores, and requirement for rescue analgesia. Results—Propofol and isoflurane requirements and preoperative pain scores were not different between groups. During recovery, dysphoria prevented pain evaluation at 5 minutes. Pain scores at 20 minutes were significantly lower in the methadone group, and 6 of 10 cats in the butorphanol group received rescue analgesia, making subsequent pain score comparisons inapplicable. After 6 hours, only 3 of 12 cats in the methadone group had received rescue analgesia. Conclusions and Clinical Relevance—In the present study, methadone appeared to be a better postoperative analgesic than butorphanol and provided effective analgesia for 6 hours following ovariohysterectomy in most cats. (J Am Vet Med Assoc 2013;243:844–850)